Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed about submission of the Standalone Audited Financial Results of the Company for the quarter and Year ended 31st March, 2018; Auditor's Report by Statutory Auditors on Audited Financial Results for the quarter and Year ended 31st March, 2018; and declaration pursuant to Regulation 33 (d) of (Listing Obligation and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
